Temperature-controlled equipment specialist Envirotainer has completed the integration of va-Q-tec’s pharma business, advancing the future of pharma cold chain
It says that as the pharmaceutical industry faces growing demands for more reliable and flexible cold chain solutions, it has strengthened its portfolio with the addition of advanced passive cooling technology.
It adds that its extended range of solutions allow pharmaceutical companies to transport products at any temperature, size and at any stage of the product lifecycle, spanning the entire range of pharmaceuticals, from precision medicines and advanced cell and gene therapies, to commercial distribution of vaccines and chronic disease treatments to even the most challenging regions.
Services include real-time monitoring, predictive analytics and 24-hour customer assistance, supported by an expanded global network.
Envirotainer chief executive, David Simonsson (pictured), said: “This integration marks a significant step forward for our customers and company. By combining the best of active and passive technologies, we’re better equipped to meet the evolving needs of the pharmaceutical industry, helping vital medicines reach patients safely, no matter where they are.
“As we continue to innovate, sustainability remains central to our mission, and we’ll continue to offer solutions that not only protect the efficacy of medicines but also align with environmental best practices. This is the beginning of a new era for us, one where we can make an even greater impact on global health.”